127 related articles for article (PubMed ID: 19559720)
1. Quantitative determination of the biological activity of botulinum toxin type A by measuring the compound muscle action potential (CMAP) in rats.
Sakamoto T; Torii Y; Takahashi M; Ishida S; Goto Y; Nakano H; Harakawa T; Ginnaga A; Kozaki S; Kaji R
Toxicon; 2009 Nov; 54(6):857-61. PubMed ID: 19559720
[TBL] [Abstract][Full Text] [Related]
2. Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins.
Torii Y; Goto Y; Takahashi M; Ishida S; Harakawa T; Sakamoto T; Kaji R; Kozaki S; Ginnaga A
Toxicon; 2010; 55(2-3):407-14. PubMed ID: 19778548
[TBL] [Abstract][Full Text] [Related]
3. Establishment of alternative potency test for botulinum toxin type A using compound muscle action potential (CMAP) in rats.
Torii Y; Goto Y; Nakahira S; Ginnaga A
Toxicon; 2014 Nov; 90():97-105. PubMed ID: 25110177
[TBL] [Abstract][Full Text] [Related]
4. Quantification of potency of neutralizing antibodies to botulinum toxin using compound muscle action potential (CMAP).
Torii Y; Takahashi M; Ishida S; Goto Y; Nakahira S; Harakawa T; Kaji R; Kozaki S; Ginnaga A
Toxicon; 2010; 55(2-3):662-5. PubMed ID: 19781565
[TBL] [Abstract][Full Text] [Related]
5. Mouse compound muscle action potential assay: an alternative method to conduct the LD₅₀ botulinum toxin type A potency test.
Kim SH; Kim SB; Yang GH; Rhee CH
Toxicon; 2012 Sep; 60(3):341-7. PubMed ID: 22613167
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of biological activity of four botulinum toxin type A preparations in mice.
Chung ME; Song DH; Park JH
Dermatol Surg; 2013 Jan; 39(1 Pt 2):155-64. PubMed ID: 23301819
[TBL] [Abstract][Full Text] [Related]
7. The effect of botulinum toxin type A injection on compound muscle action potential in an in vivo rat model.
Cichon JV; McCaffrey TV; Litchy WJ; Knops JL
Laryngoscope; 1995 Feb; 105(2):144-8. PubMed ID: 8544593
[TBL] [Abstract][Full Text] [Related]
8. Nerve stimulation boosts botulinum toxin action in spasticity.
Frasson E; Priori A; Ruzzante B; Didonè G; Bertolasi L
Mov Disord; 2005 May; 20(5):624-9. PubMed ID: 15726575
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study.
Smuts JA; Schultz D; Barnard A
Headache; 2004 Sep; 44(8):801-5. PubMed ID: 15330827
[TBL] [Abstract][Full Text] [Related]
10. In vivo analysis of end-plate noise of human extensor digitorum brevis muscle after intramuscularly injected botulinum toxin type A.
Van Putten MJ; Padberg M; Tavy DL
Muscle Nerve; 2002 Dec; 26(6):784-90. PubMed ID: 12451602
[TBL] [Abstract][Full Text] [Related]
11. Extensor digitorum brevis test and resistance to botulinum toxin type A.
Gordon PH; Gooch CL; Greene PE
Muscle Nerve; 2002 Dec; 26(6):828-31. PubMed ID: 12451609
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Systemic Toxicity between Botulinum Toxin Subtypes A1 and A2 in Mice and Rats.
Torii Y; Goto Y; Nakahira S; Kozaki S; Kaji R; Ginnaga A
Basic Clin Pharmacol Toxicol; 2015 Jun; 116(6):524-8. PubMed ID: 25395371
[TBL] [Abstract][Full Text] [Related]
13. Effects of Botox and Neuronox on muscle force generation in mice.
Stone AV; Ma J; Whitlock PW; Koman LA; Smith TL; Smith BP; Callahan MF
J Orthop Res; 2007 Dec; 25(12):1658-64. PubMed ID: 17600825
[TBL] [Abstract][Full Text] [Related]
14. Does vitamin B alter the efficacy of botulinum toxin?
Tatlidede S; Baslo MB; Özkaya Ö; Soydan T; Orhan EK; Yeşilada AK
Aesthetic Plast Surg; 2012 Jun; 36(3):692-7. PubMed ID: 22395300
[TBL] [Abstract][Full Text] [Related]
15. The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans.
Eleopra R; Tugnoli V; De Grandis D
Mov Disord; 1997 Jan; 12(1):89-94. PubMed ID: 8990059
[TBL] [Abstract][Full Text] [Related]
16. Effects of treadmill running on rat gastrocnemius function following botulinum toxin A injection.
Tsai SW; Chen CJ; Chen HL; Chen CM; Chang YY
J Orthop Res; 2012 Feb; 30(2):319-24. PubMed ID: 21815203
[TBL] [Abstract][Full Text] [Related]
17. [Qualitative analysis on the denervating action of botulinum toxin A in gel].
Chen JC; Mai GH; Yu XP; Yu HY; Wu HP; Jiang FT
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):104-7. PubMed ID: 21141570
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological study for comparing the effect of biological activity between type A botulinum toxins in rat gastrocnemius muscle.
Kim CS; Jang WS; Son IP; Nam SH; Kim YI; Park KY; Kim BJ; Kim MN
Hum Exp Toxicol; 2013 Sep; 32(9):914-20. PubMed ID: 23475433
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle.
Dodd SL; Selsby J; Payne A; Judge A; Dott C
Toxicon; 2005 Aug; 46(2):196-203. PubMed ID: 15975617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
